Elite Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Elite Pharmaceuticals, Inc. (ELTP) had Lessee, Operating Lease, Liability, to be Paid, Year One of $18.87 thousand as of 2023-12-31, per its 10-Q filed 2024-02-14.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-02-14
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $18.87K.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.16K; Lessee, Operating Lease, Liability, to be Paid, Year One as first filed $15.21K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $14.84K.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $14.77K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2023-12-31 | $18.87K 10-Q · filed 2024-02-14 | |
| 2023-03-31 | $2.16K 10-Q · filed 2023-11-14 | $15.21K 10-K · filed 2023-06-29 |
| 2022-12-31 | $14.84K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $14.77K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $254.05K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $259.79K 10-K · filed 2022-06-29 | |
| 2021-12-31 | $259.79K 10-Q · filed 2022-02-14 |